The effect of plant stanol- and sterol-enriched foods on lipid metabolism, serum lipids and coronary heart disease

被引:35
|
作者
Gylling, H
Miettinen, TA
机构
[1] Univ Helsinki, Biomedicum Helsinki, Dept Med, Div Internal Med, FIN-00029 Helsinki, Finland
[2] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
[3] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
D O I
10.1258/0004563054255605
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Phytosterols are plant sterols, mainly campesterol and sitosterol, and their respective stanols (5 alpha-saturated derivatives), which chemically resemble cholesterol. They are present in a normal diet and are absorbed proportionally to cholesterol, but to a much lesser extent, such that less than 0.1% of serum sterols are plant sterols. Phytosterols inhibit intestinal cholesterol absorption, and fat-soluble plant stanol esters were introduced as a functional food for lowering serum cholesterol in the early 1990s; plant sterol esters entered the market at the end of the 1990s. Inhibition of the intestinal absorption of cholesterol stimulates cholesterol synthesis, a factor which limits serum cholesterol lowering to about 10% with phytosterols. Enrichment of the diet with plant stanol esters reduces absorption and serum concentrations of both cholesterol and plant sterols, whereas enrichment of the diet with plant sterol esters, especially in combination with statins, lowers serum cholesterol but increases serum plant sterol levels. Recent studies have suggested that high-serum plant sterol levels may be associated with increased coincidence of coronary heart disease. Estimates of coronary heart disease reduction by 20-25% with plant sterols/stanols is based mainly on short-term studies. Long-term cholesterol lowering, needed for the prevention of coronary heart disease, may be successful with plant stanol esters, which lower serum cholesterol in both genders over at least a year.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 40 条
  • [21] Gene: environment interaction in lipid metabolism and effect on coronary heart disease risk
    Talmud, PJ
    Humphries, SE
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) : 149 - 154
  • [22] THE EFFECT OF THRESHOLD EXERCISE ON SERUM-LIPIDS IN PATIENTS WITH CORONARY HEART-DISEASE
    BELYAVSKY, VI
    SAPRYGIN, DB
    PORUCHIKOV, EA
    GORBUNOV, GI
    CHUSOVKOVA, TS
    KARDIOLOGIYA, 1985, 25 (08) : 85 - 86
  • [23] CORRELATION OF SERUM-LIPIDS, LIPOPROTEINS, LIPID PEROXIDE PRODUCTS AND METALS WITH CORONARY HEART-DISEASE
    WEN, Y
    QIAN, XX
    JIA, GL
    GAO, SB
    JIN, YF
    HAN, DY
    HE, SF
    CHINESE MEDICAL JOURNAL, 1993, 106 (03) : 167 - 170
  • [24] EFFECT OF LONG-ACTING NITRITES ON SERUM-LIPIDS IN PATIENTS WITH CORONARY HEART-DISEASE
    KLEIN, WW
    PRISTAUTZ, H
    PAVEK, P
    BRANDT, D
    FLUCH, N
    BORKENSTEIN, J
    ZEITSCHRIFT FUR KARDIOLOGIE, 1974, 63 (08): : 713 - 718
  • [25] THE EFFECT OF EXERCISE ON LIPID-METABOLISM IN PATIENTS WITH LIMB STUMPS AND CONCURRENT CORONARY HEART-DISEASE
    KAZNACHEEV, LN
    LYUSOV, VA
    NEVEROV, IV
    NOVIKOV, VT
    CHURILOV, VP
    KOZLOVA, RI
    GLASHKOVA, RP
    TURITSYNA, IG
    KARDIOLOGIYA, 1984, 24 (02) : 109 - 110
  • [26] Effect of a diet to control serum lipids and cholesterol levels in patients with coronary heart disease (CHD) using statins
    Nacif, Marcia A. L.
    Damasceno, Nagila R. T.
    Torres, Elizabeth A. F. S.
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 263 - 263
  • [27] Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study
    Luan, Hemi
    Chen, Xiaomin
    Zhong, Shilong
    Yuan, Xune
    Meng, Nan
    Zhang, Jianfeng
    Fu, Jin
    Xu, Ran
    Lee, Connie
    Song, Siyuan
    Jiang, Hui
    Xu, Xun
    BIOMARKERS, 2013, 18 (04) : 314 - 321
  • [28] APOE polymorphism is associated with blood lipid and serum uric acid metabolism in hypertension or coronary heart disease in a Chinese population
    Wang, Canwang
    Yan, Wanli
    Wang, Huan
    Zhu, Jingkang
    Chen, Hui
    PHARMACOGENOMICS, 2019, 20 (14) : 1021 - 1031
  • [29] THE EFFECT OF ESTROGENS ON LIPID-METABOLISM IN PATIENTS WITH CLIMACTERIC MYOCARDIODYSTROPHY ALONE AND COMBINED WITH CORONARY HEART-DISEASE
    KRETOVA, NE
    NEVEROV, IV
    NOVIKOV, VT
    KOZLOVA, RI
    SPINOVA, RP
    SMIRNOVA, AA
    KLINICHESKAYA MEDITSINA, 1984, 62 (03): : 81 - 85
  • [30] The effect of atorvastatin on serum phospholipase A2 IIA type and lipids composition of LDL particles in patients with coronary heart disease
    Pirkova, A. A.
    Ezhov, M. V.
    Samoilova, E. V.
    Samoilenco, E. Y.
    Korotaeva, A. A.
    Naumov, V. G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 581 - 581